Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 185

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Intimal Sarcoma Is the Most Frequent Primary Cardiac Sarcoma: Clinicopathologic and Molecular Retrospective Analysis of 100 Primary Cardiac Sarcomas

Neuville, Agnès, Collin, Françoise, Bruneval, Patrick, Parrens, Marie, Thivolet, Françoise, Gomez-Brouchet, Anne, Terrier, Philippe, de Montpreville, Vincent Thomas, Le Gall, François, Hostein, Isabelle, Lagarde, Pauline, Chibon, Frédéric, Coindre, Jean-Michel · 2014 · American Journal of Surgical Pathology

Abstract

We report novel molecular and pathologic features of sarcomas involving the heart. Intimal sarcoma appears as the most frequent primary cardiac sarcoma within the largest described series of 100 primary cardiac sarcomas. Immunohistochemical analysis, fluorescence in situ hybridization, real-time polymerase chain reaction, and array-comparative genomic hybridization were performed on materials from 65 women and 35 men, aged 18 to 82 years (mean 50 y), retrieved from the French Departments of Pathology, between 1977 and early 2013. Right and left heart was involved in 44 and 56 cases, respectively. There were 42 intimal sarcomas, 26 angiosarcomas, 22 undifferentiated sarcomas, 7 synovial sarcomas, 2 leiomyosarcomas, and 1 peripheral neuroectodermal tumor. All but 1 angiosarcomas originated from the right heart, whereas 83% of the intimal sarcomas and 72% of the undifferentiated sarcomas were from the left heart. MDM2 overexpression was immunohistochemically observed in all intimal sarcomas, as well as in 10 of the 22 undifferentiated sarcomas and in 5 of the 26 angiosarcomas. MDM2 amplification was only demonstrated in intimal sarcomas. Genomic analysis showed a complex profile, with recurrent 12q13-14 amplicon involving MDM2, 4q12 amplicon involving KIT and PDGFRA, 7p12 gain involving EGFR, and 9p21 deletion targeting CDKN2A. Immunohistochemical detection of MDM2 overexpression can easily detect intimal sarcoma, provided that molecular aberration is proved. As resections are limited to the left atrium, this histologic subtype could benefit from therapies targeting PDGFRA or MDM2.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/pas.0000000000000184

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Metadata

Authors
Neuville, A., Collin, F., Bruneval, P., Parrens, M., Thivolet, F., Gomez-Brouchet, A., Terrier, P., de Montpreville, V. T., Le Gall, F., Hostein, I., Lagarde, P., Chibon, F., & Coindre, J.-M.
Venue
American Journal of Surgical Pathology
Published
2014-04
Volume
38
Issue
4
Pages
461-469
ISSN
0147-5185 (ISSN-L)
OpenAlex
W1963656068
Cited by
185
References
1
FWCI
9.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intimal Sarcoma Is the Most Frequent Primary Cardiac Sarcoma: Clinicopathologic and Molecular Retrospective Analysis of 100 Primary Cardiac Sarcomas. https://app.cochat.ai/papers/10.1097/pas.0000000000000184
The paper
Neuville, A., Collin, F., Bruneval, P., Parrens, M., Thivolet, F., Gomez-Brouchet, A., Terrier, P., de Montpreville, V. T., Le Gall, F., Hostein, I., Lagarde, P., Chibon, F., & Coindre, J.-M. (2014). Intimal Sarcoma Is the Most Frequent Primary Cardiac Sarcoma: Clinicopathologic and Molecular Retrospective Analysis of 100 Primary Cardiac Sarcomas. American Journal of Surgical Pathology. https://doi.org/10.1097/pas.0000000000000184

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.